Your browser doesn't support javascript.
loading
Ulinastatin ameliorates the malignant progression of prostate cancer cells by blocking the RhoA/ROCK/NLRP3 pathway.
Liu, Zhiguang; Zhu, Xiaochun; Xu, Chenglin; Min, Feng; Yu, Guofeng; Chen, Chuhong.
Affiliation
  • Liu Z; Department of Urology, Guangming Traditional Chinese Medicine Hospital of Pudong New Area, Shanghai, China.
  • Zhu X; Department of Urology, Guangming Traditional Chinese Medicine Hospital of Pudong New Area, Shanghai, China.
  • Xu C; Department of Urology, Guangming Traditional Chinese Medicine Hospital of Pudong New Area, Shanghai, China.
  • Min F; Department of Urology, Guangming Traditional Chinese Medicine Hospital of Pudong New Area, Shanghai, China.
  • Yu G; Department of Urology, Jinshan Branch of Shanghai Sixth People's Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Chen C; Department of Urology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.
Drug Dev Res ; 84(1): 36-44, 2023 02.
Article in En | MEDLINE | ID: mdl-36461611
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Inflammasomes Limits: Humans / Male Language: En Journal: Drug Dev Res Year: 2023 Document type: Article Affiliation country: China Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Inflammasomes Limits: Humans / Male Language: En Journal: Drug Dev Res Year: 2023 Document type: Article Affiliation country: China Country of publication: Estados Unidos